McDaniel Terry & Co’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

McDaniel Terry & Co’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,390	Closed	-$18K	–	85
2019 Q4	$18K	Buy	1,390 +263	+23%	+$2.43K	﹤0.01%	83
2019 Q3	$12K	Sell	1,127 -263	-19%	-$3.44K	﹤0.01%	82
2019 Q2	$24K	Hold	1,390	–	–	﹤0.01%	64
2019 Q1	$47K	Hold	1,390	–	–	0.01%	64
2018 Q4	$41K	Sell	1,390 -300	-18%	-$13.3K	0.01%	60
2018 Q3	$104K	Buy	1,690 +300	+22%	+$20.3K	0.02%	62
2018 Q2	$103K	Hold	1,390	–	–	0.02%	66
2018 Q1	$91K	Sell	1,390 -1,000	-42%	-$75.5K	0.02%	60
2017 Q4	$201K	Sell	2,390 -1,200	-33%	-$118K	0.04%	59
2017 Q3	$415K	Sell	3,590 -3,237	-47%	-$341K	0.08%	44
2017 Q2	$797K	Sell	6,827 -784	-10%	-$97.3K	0.15%	35
2017 Q1	$939K	Hold	7,611	–	–	0.18%	33
2016 Q4	$1.04M	Sell	7,611 -350	-4%	-$62.1K	0.22%	33
2016 Q3	$1.58M	Sell	7,961 -500	-6%	-$86.1K	0.34%	28
2016 Q2	$1.1M	Hold	8,461	–	–	0.25%	30
2016 Q1	$791K	Buy	8,461 +5,077	+150%	+$553K	0.19%	30
2015 Q4	$686K	Buy	3,384 +1,707	+102%	+$305K	0.18%	32
2015 Q3	$244K	Buy	+1,677	New	+$308K	0.07%	40

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

McDaniel Terry & Co's BLCM Position: Q1 2020 in Review

McDaniel Terry & Co sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2020, closing a stake of 1,390 shares — an estimated $18K sold.

McDaniel Terry & Co first reported a position in BLCM in Q3 2015 and held it in 18 quarters. The position peaked at $1.58M in Q3 2016. 29 funds tracked by Wall St. Rank hold BLCM as of Q1 2020.

McDaniel Terry & Co reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
McDaniel Terry & Co sold 1,390 Bellicum Pharmaceuticals, Inc. shares in Q1 2020, an estimated $18K.
McDaniel Terry & Co first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2015 and held it in 18 quarters.
McDaniel Terry & Co's Bellicum Pharmaceuticals, Inc. position peaked at $1.58M in Q3 2016.
29 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2020.

Based on McDaniel Terry & Co's 13F filing for Q1 2020, filed 8 May 2020.